Filed with the SEC as Altman Peter; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: bought $34K of BCDA. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $34KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
BCDABought: BioCardia, Inc. Oct 16, 2026300 sharesfiled Oct 20, 2026385,385 shares held directly after, as filedfiling$285
BCDABought: BioCardia, Inc. Oct 15, 2026200 sharesfiled Oct 20, 2026385,085 shares held directly after, as filedfiling$190
BCDABought: BioCardia, Inc. Sep 29, 20261,000 sharesfiled Sep 30, 2026384,885 shares held directly after, as filedfiling$1K
BCDABought: BioCardia, Inc. Sep 23, 20261,900 sharesfiled Sep 23, 2026383,885 shares held directly after, as filedfiling$2K
BCDABought: BioCardia, Inc. Sep 3, 2026800 sharesfiled Sep 4, 2026381,985 shares held directly after, as filedfiling$872
BCDABought: BioCardia, Inc. Aug 17, 20265,400 sharesfiled Aug 18, 2026381,115 shares held directly after, as filedfiling$5K
BCDABought: BioCardia, Inc. Aug 13, 20261,900 sharesfiled Aug 13, 2026375,785 shares held directly after, as filedfiling$2K
BCDABought: BioCardia, Inc. Jul 29, 20265,000 sharesfiled Jul 29, 2026373,885 shares held directly after, as filedfiling$4K
BCDABought: BioCardia, Inc. Jul 17, 2026500 sharesfiled Jul 20, 2026368,885 shares held directly after, as filedfiling$415
BCDABought: BioCardia, Inc. Jul 15, 20261,500 sharesfiled Jul 15, 2026368,385 shares held directly after, as filedfiling$1K
BCDABought: BioCardia, Inc. Jul 14, 20262,800 sharesfiled Jul 15, 2026366,885 shares held directly after, as filedfiling$2K
BCDABought: BioCardia, Inc. Jul 10, 20261,000 sharesfiled Jul 10, 2026369,485 shares held directly after, as filedfiling$940
BCDABought: BioCardia, Inc. Jul 9, 20261,000 sharesfiled Jul 10, 2026368,485 shares held directly after, as filedfiling$900
BCDABought: BioCardia, Inc. Jun 18, 2026800 sharesfiled Jun 22, 2026300,566 shares held directly after, as filedfiling$768
BCDABought: BioCardia, Inc. Jun 17, 20261,500 sharesfiled Jun 22, 2026299,766 shares held directly after, as filedfiling$1K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Other Form 4 entries
Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.
BCDA: grant or award (code A), 1 entry, Jun 29, 2026
BCDA: shares withheld for tax or exercise price (code F), 1 entry, Jul 2, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.
